BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35412367)

  • 1. Deep Learning Prediction of Ovarian Malignancy at US Compared with O-RADS and Expert Assessment.
    Chen H; Yang BW; Qian L; Meng YS; Bai XH; Hong XW; He X; Jiang MJ; Yuan F; Du QW; Feng WW
    Radiology; 2022 Jul; 304(1):106-113. PubMed ID: 35412367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
    Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; MCourt CK; Mutch DG; Powell MA; Siegel CL
    Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Validation of O-RADS US Risk Stratification and Management System.
    Hack K; Gandhi N; Bouchard-Fortier G; Chawla TP; Ferguson SE; Li S; Kahn D; Tyrrell PN; Glanc P
    Radiology; 2022 Jul; 304(1):114-120. PubMed ID: 35438559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
    Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
    JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced US to Improve Diagnostic Performance of O-RADS US Risk Stratification System for Malignancy.
    Yuan K; Huang YJ; Mao MY; Li T; Wang SJ; He DN; Liu WF; Li MX; Zhu XM; Chen XY; Zhu YX
    Radiology; 2023 Aug; 308(2):e223003. PubMed ID: 37552073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an ultrasound-based deep learning radiomics nomogram for predicting the malignant risk of ovarian tumours.
    Du Y; Xiao Y; Guo W; Yao J; Lan T; Li S; Wen H; Zhu W; He G; Zheng H; Chen H
    Biomed Eng Online; 2024 Apr; 23(1):41. PubMed ID: 38594729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of benign and malignant ovarian tumors using Resnet34 on ultrasound images.
    Miao K; Zhao N; Lv Q; He X; Xu M; Dong X; Li D; Shao X
    J Obstet Gynaecol Res; 2023 Dec; 49(12):2910-2917. PubMed ID: 37696522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
    Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
    Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses.
    Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN
    J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-based deep learning radiomics model for differentiating benign, borderline, and malignant ovarian tumours: a multi-class classification exploratory study.
    Du Y; Guo W; Xiao Y; Chen H; Yao J; Wu J
    BMC Med Imaging; 2024 Apr; 24(1):89. PubMed ID: 38622546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups.
    Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
    JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound image analysis using deep neural networks for discriminating between benign and malignant ovarian tumors: comparison with expert subjective assessment.
    Christiansen F; Epstein EL; Smedberg E; Åkerlund M; Smith K; Epstein E
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):155-163. PubMed ID: 33142359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Combing O-RADS US and CA-125 Improve Diagnostic Accuracy in Assessing Adnexal Malignancy Risk in Women With Different Menopausal Status?
    Wu M; Wang Q; Zhang M; Cao J; Chen Y; Zheng J; Luo L; Su M; Lin X; Kuang X; Zhang X
    J Ultrasound Med; 2023 Feb; 42(3):675-685. PubMed ID: 35880406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-RADS MRI Classification of Indeterminate Adnexal Lesions: Time-Intensity Curve Analysis Is Better Than Visual Assessment.
    Wengert GJ; Dabi Y; Kermarrec E; Jalaguier-Coudray A; Poncelet E; Porcher R; Thomassin-Naggara I; Rockall AG;
    Radiology; 2022 Jun; 303(3):566-575. PubMed ID: 35230183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of American College of Radiology Ovarian-Adnexal Reporting and Data System ultrasound to predict malignancy risk in adnexal lesions.
    Li Y; Shao G; Wu M; Zhang F; Zhang Y; Shao C
    J Obstet Gynaecol Res; 2024 Feb; 50(2):225-232. PubMed ID: 37990446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram based on the O-RADS for predicting the malignancy risk of adnexal masses with complex ultrasound morphology.
    Gong LP; Li XY; Wu YN; Dong S; Zhang S; Feng YN; Lv YE; Guo XJ; Peng YQ; Du XS; Tian JW; Sun CX; Sun LT
    J Ovarian Res; 2023 Mar; 16(1):57. PubMed ID: 36945000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of sonographic subjective tumor assessment, IOTA logistic regression model 1, IOTA Simple Rules and GI-RADS system in the preoperative prediction of malignancy in women with adnexal masses.
    Koneczny J; Czekierdowski A; Florczak M; Poziemski P; Stachowicz N; Borowski D
    Ginekol Pol; 2017; 88(12):647-653. PubMed ID: 29303221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. US Risk Stratification System for Follicular Thyroid Neoplasms.
    Li J; Li C; Zhou X; Huang J; Yang P; Cang Y; Zhai H; Huang R; Mu Y; Gou X; Zhang Y; Yu J; Liang P
    Radiology; 2023 Nov; 309(2):e230949. PubMed ID: 37987664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.